{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-083220","form_type":"8-K","ticker":"ELDN","cik":"0001404281","company_name":"Eledon Pharmaceuticals, Inc.","filed_at":"2024-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.930703+00:00","generated_at":"2026-05-31T20:59:44.533856+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Eledon Pharmaceuticals replaces auditor KMJ Corbin with Crowe LLP; no disagreements reported","bullets":["Audit committee dismissed KMJ Corbin and appointed Crowe LLP on July 10, 2024, after KMJ partners joined Crowe.","KMJ's reports for fiscal years 2022 and 2023 contained no adverse opinion but included a going concern explanatory paragraph.","No disagreements or reportable events occurred during the two most recent fiscal years and subsequent interim period.","KMJ provided a letter agreeing with the company's statements, filed as Exhibit 16.1."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-083220","json":"https://secwatch.observer/filing/0000950170-24-083220.json","markdown":"https://secwatch.observer/filing/0000950170-24-083220.md","text":"https://secwatch.observer/filing/0000950170-24-083220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1404281/000095017024083220/0000950170-24-083220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1404281/000095017024083220/eldn-20240710.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:59:44.533856+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}